$0.99
▲ +3.9% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
Tempest Therapeutics Registers 2.43 Million Shares for Resale
Overview
52-week range
$1.24
$12
0% of range
Avg surprise (last 3)
-10.5%
Avg reaction (last 2)
+6.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.51 | $-0.28 | -82.1% | +83.9% | +13.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.79 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-2.07 | $-3.23 | +35.9% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-3.16 | $-3.71 | +14.8% | — | -1.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-5.32 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.52 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-4.62 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.48 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.54 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.30 | -$2.07 | +85.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-28M | — | $-4M | $-8M | $-11M | — | $-11M | $-10M |
| Net income | $-28M | — | $-4M | $-8M | $-11M | — | $-11M | $-10M |
| EPS (diluted) | $-2.53 | — | $-0.79 | $-2.07 | $-3.16 | — | $-5.32 | $-5.52 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $8M | $8M | $14M | $22M | $30M | $22M | $31M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $2M | $8M | $8M | $15M | $22M | $31M | $24M | $32M |
| Total assets | $11M | $17M | $17M | $24M | $32M | $41M | $34M | $42M |
| Long-term debt | — | — | — | — | — | — | $0 | $2M |
| Total liabilities | $10M | $10M | $11M | $15M | $21M | $22M | $22M | $25M |
| Total equity | $822,000 | $7M | $6M | $10M | $11M | $19M | $11M | $17M |
Implied volatility — last 90 days
No IV snapshots yet for TPST.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.